158 related articles for article (PubMed ID: 7270403)
1. Problems in assessment of new pharmacologic agents for the heart failure patient.
Rude RE; Grossman W; Colucci WS; Benotti JR; Carabello BA; Wynne J; Malacoff R; Braunwald E
Am Heart J; 1981 Sep; 102(3 Pt 2):584-90. PubMed ID: 7270403
[TBL] [Abstract][Full Text] [Related]
2. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Taylor CR; Baird JR; Blackburn KJ; Cambridge D; Constantine JW; Ghaly MS; Hayden ML; McIlhenny HM; Moore PF; Olukotun AY; Pullman LG; Salsburg DS; Saxton CA; Shevde S
Am Heart J; 1981 Sep; 102(3 Pt 2):515-32. PubMed ID: 7023221
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
[TBL] [Abstract][Full Text] [Related]
5. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
Bottorff MB; Rutledge DR; Pieper JA
Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
[TBL] [Abstract][Full Text] [Related]
7. Combination of positive inotropic and vasodilating substances in congestive heart failure.
Cantelli I; Bracchetti D
Cardiovasc Drugs Ther; 1988 May; 2(1):83-91. PubMed ID: 3154699
[TBL] [Abstract][Full Text] [Related]
8. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of intravenous amrinone in patients with congestive heart failure.
Goldstein RA
Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
[TBL] [Abstract][Full Text] [Related]
10. Intravenous use of amrinone for the treatment of the failing heart.
Mancini D; LeJemtel T; Sonnenblick E
Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
Weber KT; Andrews V; Kinasewitz GT; Janicki JS; Fishman AP
Am Heart J; 1981 Sep; 102(3 Pt 2):569-77. PubMed ID: 6115574
[TBL] [Abstract][Full Text] [Related]
13. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Robinson PJ; Lvoff R; Chong B; Barrett PA
Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
[TBL] [Abstract][Full Text] [Related]
14. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
[TBL] [Abstract][Full Text] [Related]
15. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
Thormann J; Kramer W; Dieterich HA
Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
[TBL] [Abstract][Full Text] [Related]
16. New positive inotropic drugs for the treatment of congestive heart failure.
Sonnenblick EH; Mancini DM; LeJemtel TH
Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic evaluation of cardiovascular effects of amrinone.
Modena MG; Benassi A; Mattioli G
Clin Cardiol; 1984 Nov; 7(11):593-8. PubMed ID: 6499289
[TBL] [Abstract][Full Text] [Related]
18. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Alousi AA; Canter JM; Fort DJ
Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
[TBL] [Abstract][Full Text] [Related]
20. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
